RIGHTS AGREEMENT TITAN PHARMACEUTICALS, INC. and Continental Stock Transfer & Trust Company, as Rights Agent Dated May 28, 2013Rights Agreement • May 29th, 2013 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
Rights Agreement, dated as of May 28, 2013 (as amended, supplemented or otherwise modified from time to time, the “Rights Agreement”) between Titan Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Continental Transfer & Trust Company, a New York banking corporation (the “Rights Agent”).
CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[*******]” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES...License Agreement • May 29th, 2013 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Reference is made to the License Agreement dated December 14, 2012 between Titan Pharmaceuticals, Inc. and Braeburn Pharmaceuticals Sprl (the “Agreement”). This is to confirm our agreement as follows:
